http://www.regorpharma.com/about.html WebRegor Pharmaceuticals Inc 2024 - Present 5 years. Cambridge, MA Associate Director of Biology Catabasis Pharmaceuticals, Inc. 2012 - …
Eric Wesoloski - Executive Direct.. - Regor Therapeutics ZoomInfo
WebOct 4, 2024 · By Marjorie E. Zettler, Ph.D., MPH, executive director of clinical science, Regor Pharmaceuticals, Inc. First launched in February 2024 by the FDA’s Oncology Center of Excellence, the Real-Time Oncology Review (RTOR) program is intended to streamline the review process for oncology drug applications. WebFounded in 2024 by a team of accomplished scientists with a proven track record in drug discovery and executive leadership in top global biopharmaceutical companies, Regor is a … We have embarked upon three therapeutic areas, Metabolic diseases, Oncology, and … With a proactive mindset, we aggressively employ advanced and internally … At Regor, we aspire to be the starts of hope for patients. We are committed to … Shanghai, April. 12, 2024 --Regor Therapeutics Group, a clinical-stage … Regor Pharmaceuticals Inc. 245 Main Street, Second Floor Cambridge, MA … Regor HPK1 Inhibitor AACR EORTC 2024 Poster Presentation Discovery of A … At Regor,our employees are our most valuable assets. We strive to create a … Prior to founding Regor, he was an Executive Director at Pfizer-Connecticut … kids baseball practice gear
Pfizer Sues Former Employees For Stolen Trade Secrets
WebDec 17, 2024 · Lilly strikes deals with the biotechs Foghorn and Regor. Eli Lilly and Company will pay Foghorn Therapeutics, a 5-year-old biotech firm, $300 million and buy $80 million of its stock as part of a ... WebRegor Therapeutics Group 250 followers on LinkedIn. We aspire to be a world class innovative drug discovery company from China. Regor Therapeutics is a clinical stage … Web1 Regor’s discovery team published their Structural Biology work on the human glucagon-like peptide-1 receptor (GLP1R) in June 18, 2024 issue of Nature Communications. Regor’s … is mgmt still around